Caricamento...
Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States
Background: The Intercept Blood System (IBS) for platelets has been developed to reduce pathogen transmission risks during transfusions. Objective: This study was a comprehensive economic analysis of the cost-effectiveness of using the IBS for single-donor apheresis platelets (AP) and random-donor p...
Salvato in:
| Pubblicato in: | Clin Ther |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Published by Elsevier Inc.
2003
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7133650/ https://ncbi.nlm.nih.gov/pubmed/14604745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0149-2918(03)80288-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|